Sugi Predict

Sugi Predict / Compounds / SCHEMBL30427995

SCHEMBL30427995

SCHEMBL30427995

CC(=O)N[C@H]1[C@H](O[C@@H]2[C@H](O[C@]3(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@@H](CO)O[C@]4(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O4)O3)[C@@H](O)[C@H](O)O[C@@H]2CO)O[C@H](CO)[C@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.68

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ SIGLEC7 Q9Y286 6/20 0.68
▸ SELP P16109 2/20 0.64
▸ SELL P14151 1/20 0.64
▸ MAG P20916 7/20 0.60
▸ SELE P16581 4/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29782338 1.00 SIGLEC7 (0.68) SIGLEC7SELPSELLMAGSELE
SCHEMBL30147370 0.97 SIGLEC7 (0.71) SIGLEC7SELPSELLMAGSELE
SCHEMBL29615881 0.97 SIGLEC7 (0.71) SIGLEC7SELPSELLMAGSELE
SCHEMBL29615718 0.97 SIGLEC7 (0.71) SIGLEC7SELPSELLMAGSELE
SCHEMBL29615820 0.97 SIGLEC7 (0.71) SIGLEC7SELPSELLMAGSELE
SCHEMBL30361171 0.97 SIGLEC7 (0.71) SIGLEC7SELPSELLMAGSELE
SCHEMBL31700327 0.96 SIGLEC7 (0.70) SIGLEC7SELPSELLMAGSELE
SCHEMBL31701543 0.96 SIGLEC7 (0.70) SIGLEC7SELPSELLMAGSELE
SCHEMBL31700314 0.94 SIGLEC7 (0.73) SIGLEC7SELPSELLMAGSELE
SCHEMBL31179876 0.94 SIGLEC7 (0.73) SIGLEC7SELPSELLMAGSELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3341411-B1 ANTI-SIGLEC-7 ANTIBODIES AND METHODS OF USE THEREOF ALECTOR LLC (US) 2025-06-11 — — EP disclosed
EP-4149625-A2 TREATMENT OF KNOWN AND UNKNOWN VIRAL INFECTION WITH LIPID AGENTS Viratides, LLC (US) 2023-03-22 — — EP disclosed
Send feedback